Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control
IrelandStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
IrelandStudy on the Effects of Triumeq (Abacavir Sulfate, Lamivudine, Dolutegravir Sodium) in Patients with Amyotrophic Lateral Sclerosis (ALS)
IrelandStudy of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma
IrelandStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
IrelandStudy of atropine sulfate eye drops (0.
HungaryStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
IrelandStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
IrelandStudy on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer's Disease Due to Genetic Mutation
IrelandStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
IrelandStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
IrelandStudy on Darolutamide with Standard Therapy for Patients with High-Risk Localized Prostate Cancer
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
